Showing results 142 to 161 of 173
< previous
next >
| Issue Date | Title | Author(s) |
| Apr-2013 | The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy | Baran, Yusuf ; Ceylan, Çağatay ; Camgöz, Aylin |
| 2010 | The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells | Baran, Yusuf ; Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur |
| Nov-2019 | Sensitization of Philadelphia positive acute lymphoblastic leukemia cells resistant to imatinib by targeting sphingolipid metabolism | Kiraz, Yağmur |
| Jun-2011 | Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A | Salas, Arelis; Ponnusamy, Suriyan; Senkal, Can E.; Meyers-Needham, Marisa; Selvam, Shanmugam Panneer; Saddoughi, Sahar A.; Apohan, Elif; Sentelle, R. David; Smith, Charles; Gault, Christopher R.; Obeid, Lina M.; El-Shewy, Hesham M.; Oaks, Joshua; Santhanam, Ramasamy; Marcucci, Guido; Baran, Yusuf ; Mahajan, Sandeep; Fernandes, Daniel; Stuart, Robert; Perrotti, Danilo; Öğretmen, Besim |
| 2015 | Sphingosine-1-phosphate receptor 2/GQ/Phospholıpase C Axis is a novel mechanism to overcome nilotinib resistance in T315I mutation expressing 32DCL3 murine cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
| Jul-2013 | STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells | Kiper, Hatice Demet; Tezcanlı Kaymaz, Burçin; Adan Gökbulut, Aysun ; Selvi, Nur; Biray Avcı, Çığır; Kosova, Buket; İskender, Güniz; Kartal Yandım, Melis; Gündüz, Cumhur; Şahin, Fahri; Baran, Yusuf ; Saydam, Güray |
| 2007 | A study of multiple drug resistance mechanisms improved against Bortezomib on multiple myeloma cell lines in vitro | Uyuklu, Tolga; Ural, A. Uğur; Sarper, Metal; Avcu, Ferit; Baran, Yusuf ; Elçi, Pınar; Akar, Nejat |
| 2014 | Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis | Tezcanlı Kaymaz, Burçin; Selvi, Nur; Adan Gökbulut, Aysun ; Aktan, Çağdaş; Gündüz, Cumhur; Saydam, Güray; Baran, Yusuf ; Kosova, Buket |
| Oct-2010 | Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells | Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur; Dalmızrak, Ayşegül; Yandım, Melis Kartal; Gündüz, Ufuk; Baran, Yusuf |
| 2015 | Synergistic apoptotic effects of bortezomib and methylstat inhibitor on different multiple myeloma cell lines | Kacı, Fatma Necmiye |
| 2015 | Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines | Kacı, Necmiye; Kiraz, Yağmur ; Baran, Yusuf |
| 2020 | Synergistic apoptotic effects of bortezomib and methylstat on multiple myeloma cells | Kaci, Fatma Necmiye; Kiraz, Yağmur ; Çekdemir, Demet; Baran, Yusuf |
| Jan-2017 | Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivatives | Apohan, Elif; Yılmaz, Ülkü; Yılmaz, Özgür; Serindağ, Ayfer; Küçükbay, Hasan; Yeşilada, Özfer; Baran, Yusuf |
| Jan-2016 | T cells in tumor microenvironment | Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten |
| 2009 | Targeting ceramide metabolism increased sensitivity of Philadelphia positif chronic megacaryoblastic leukemia cells to dasatinib | Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| Mar-2015 | Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line | Tüfekçi, Özlem; Kartal Yandım, Melis; Ören, Hale; İrken, Gülersu; Baran, Yusuf |
| Oct-2011 | Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation | Baran, Yusuf ; Bielawski, Jacek; Gündüz, Ufuk; Öğretmen, Besim |
| 2014 | Targeting sphingosine kinase-1/spingosine-1-phosphate receptor 2 signalling pathway to overcome T315I mutation in 32DCL3 cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
| Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| May-2014 | Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |
